Your browser doesn't support javascript.
loading
Deep Visual Proteomics defines single-cell identity and heterogeneity.
Mund, Andreas; Coscia, Fabian; Kriston, András; Hollandi, Réka; Kovács, Ferenc; Brunner, Andreas-David; Migh, Ede; Schweizer, Lisa; Santos, Alberto; Bzorek, Michael; Naimy, Soraya; Rahbek-Gjerdrum, Lise Mette; Dyring-Andersen, Beatrice; Bulkescher, Jutta; Lukas, Claudia; Eckert, Mark Adam; Lengyel, Ernst; Gnann, Christian; Lundberg, Emma; Horvath, Peter; Mann, Matthias.
Afiliação
  • Mund A; Proteomics Program, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. andreas.mund@cpr.ku.dk.
  • Coscia F; Proteomics Program, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Kriston A; Spatial Proteomics Group, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
  • Hollandi R; Synthetic and Systems Biology Unit, Biological Research Centre, Eötvös Loránd Research Network, Szeged, Hungary.
  • Kovács F; Single-Cell Technologies Ltd., Szeged, Hungary.
  • Brunner AD; Synthetic and Systems Biology Unit, Biological Research Centre, Eötvös Loránd Research Network, Szeged, Hungary.
  • Migh E; Synthetic and Systems Biology Unit, Biological Research Centre, Eötvös Loránd Research Network, Szeged, Hungary.
  • Schweizer L; Single-Cell Technologies Ltd., Szeged, Hungary.
  • Santos A; Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany.
  • Bzorek M; Synthetic and Systems Biology Unit, Biological Research Centre, Eötvös Loránd Research Network, Szeged, Hungary.
  • Naimy S; Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany.
  • Rahbek-Gjerdrum LM; Proteomics Program, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Dyring-Andersen B; Center for Health Data Science, University of Copenhagen, Copenhagen, Denmark.
  • Bulkescher J; Big Data Institute, Li-Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, UK.
  • Lukas C; Department of Pathology, Zealand University Hospital, Roskilde, Denmark.
  • Eckert MA; Department of Pathology, Zealand University Hospital, Roskilde, Denmark.
  • Lengyel E; Department of Pathology, Zealand University Hospital, Roskilde, Denmark.
  • Gnann C; Institute for Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Lundberg E; Proteomics Program, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Horvath P; Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.
  • Mann M; Leo Foundation Skin Immunology Research Center, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Nat Biotechnol ; 40(8): 1231-1240, 2022 08.
Article em En | MEDLINE | ID: mdl-35590073
Despite the availabilty of imaging-based and mass-spectrometry-based methods for spatial proteomics, a key challenge remains connecting images with single-cell-resolution protein abundance measurements. Here, we introduce Deep Visual Proteomics (DVP), which combines artificial-intelligence-driven image analysis of cellular phenotypes with automated single-cell or single-nucleus laser microdissection and ultra-high-sensitivity mass spectrometry. DVP links protein abundance to complex cellular or subcellular phenotypes while preserving spatial context. By individually excising nuclei from cell culture, we classified distinct cell states with proteomic profiles defined by known and uncharacterized proteins. In an archived primary melanoma tissue, DVP identified spatially resolved proteome changes as normal melanocytes transition to fully invasive melanoma, revealing pathways that change in a spatial manner as cancer progresses, such as mRNA splicing dysregulation in metastatic vertical growth that coincides with reduced interferon signaling and antigen presentation. The ability of DVP to retain precise spatial proteomic information in the tissue context has implications for the molecular profiling of clinical samples.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteômica / Melanoma Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteômica / Melanoma Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article